关于侵袭性叶状乳腺癌的国际调查确定了优先研究问题
Steffi Oesterreich1, Leigh Pate2, Adrian V Lee3,4
1University of Pittsburgh, Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, Women's Cancer Research Center, Magee Womens Research Institute, Pittsburgh, PA, USA. oesterreichs@upmc.edu.
NPJ breast cancer
|July 20, 2024
概括
一项全球调查显示,需要进行更多的侵袭性叶状乳腺癌 (ILC) 研究. 专家和患者寻求改善ILC的查,早期检测和新的治疗方法,旨在个性化护理.
科学领域:
- 在瘤学瘤学.
- 翻译研究是翻译研究.
背景情况:
- 对侵袭性叶状乳腺癌 (ILC) 的认识日益增长,需要进一步的研究,以告知临床管理和治疗指南.
- 与无特殊类型 (NST) 侵袭性乳腺癌相比,了解ILC独特的病因,生物学和临床表现存在重大差距.
研究的目的:
- 调查国际临床医生,研究人员和患者,以评估目前对ILC的理解.
- 确定对侵袭性叶状乳腺癌的共识研究优先事项,以告知合作研究议程.
主要方法:
- 一项全球调查分发给1774名参与者,包括413名临床医生,376名研究人员和66个国家的1120名患者/倡导者.
- 分析参与者对区分ILC与NST的信心,对组织学的感知重要性,以及对治疗指南和临床试验的看法.
- 从不同利益相关者群体中确定研究优先事项,包括查,早期检测,成像,内分泌耐药性和新药开发.
主要成果:
- 大多数临床医生 (83%) 和研究人员 (77%) 都有信心将ILC与NST区分开来,但也承认需要改进治疗指南.
- 研究人员认为,基因组数据集中ILC的代表性不足和ILC模型不足是关键挑战.
- 患者强调医疗保健提供者对ILC独特特征的解释不足,并优先考虑改善查和早期检测.
结论:
- 对于社区知情的研究存在重大需求,以改善侵袭性叶状乳腺癌的管理和个性化治疗.
- 关键的研究重点包括加强ILC查和早期检测,开发更好的成像工具,了解内分泌抵抗,并确定新的治疗点.
- 建立国际ILC临床试验联盟由临床医生和研究人员支持,以促进合作研究和加速进展.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...